US Food and Drug Administration Chief Scott Gottlieb decided to tender his resignation which took everyone by surprise. His departure is a potential blow to the health care industry. Dr.Scott Gottleib – a physician, a medical policy expert, and public health advocate was sworn in as the 23rd Commissioner of FDA.
He became the commissioner at a critical time when healthcare was too scared and slow to adopt new changes, new technologies. The agency was worried about the hike in prices of pharmaceuticals, questionings on prescription for opioids and youth addiction to electronic cigarettes. These concerns increased the urgency of its mission to improve the downgradin...